Avadel Pharmaceuticals PLC (AVDL)
15.57
-0.25
(-1.58%)
USD |
NASDAQ |
May 23, 16:00
15.57
0.00 (0.00%)
After-Hours: 20:00
Avadel Pharmaceuticals Free Cash Flow: -127.98M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -127.98M |
| December 31, 2023 | -128.51M |
| September 30, 2023 | -115.85M |
| June 30, 2023 | -84.42M |
| March 31, 2023 | -66.49M |
| December 31, 2022 | -71.02M |
| September 30, 2022 | -78.16M |
| June 30, 2022 | -91.88M |
| March 31, 2022 | -87.94M |
| December 31, 2021 | -77.34M |
| September 30, 2021 | -74.02M |
| June 30, 2021 | -63.01M |
| March 31, 2021 | -60.64M |
| December 31, 2020 | -48.83M |
| September 30, 2020 | -37.90M |
| June 30, 2020 | -35.09M |
| March 31, 2020 | -28.75M |
| December 31, 2019 | -38.35M |
| September 30, 2019 | -54.64M |
| June 30, 2019 | -67.54M |
| March 31, 2019 | -106.08M |
| December 31, 2018 | -102.89M |
| September 30, 2018 | -93.20M |
| June 30, 2018 | -128.30M |
| March 31, 2018 | -80.06M |
| Date | Value |
|---|---|
| December 31, 2017 | -37.04M |
| September 30, 2017 | -14.65M |
| June 30, 2017 | 35.75M |
| March 31, 2017 | 22.76M |
| December 31, 2016 | 17.70M |
| September 30, 2016 | 36.01M |
| June 30, 2016 | 59.18M |
| March 31, 2016 | 77.53M |
| December 31, 2015 | 82.66M |
| September 30, 2015 | 50.18M |
| June 30, 2015 | 34.81M |
| March 31, 2015 | 15.49M |
| December 31, 2014 | -12.34M |
| September 30, 2014 | -12.99M |
| June 30, 2014 | -16.24M |
| March 31, 2014 | -16.48M |
| December 31, 2013 | -21.70M |
| September 30, 2013 | -20.91M |
| June 30, 2013 | -26.40M |
| March 31, 2013 | -27.31M |
| December 31, 2012 | -24.21M |
| September 30, 2012 | -21.76M |
| June 30, 2012 | -17.96M |
| March 31, 2012 | -11.92M |
| December 31, 2011 | -12.23M |
Free Cash Flow Range, Past 5 Years
-128.51M
Minimum
Dec 2023
-28.75M
Maximum
Mar 2020
-71.92M
Average
-69.28M
Median
Free Cash Flow Benchmarks
| Trinity Biotech PLC | -14.26M |
| Amarin Corp PLC | 1.287M |
| DBV Technologies SA | -95.40M |
| Akari Therapeutics PLC | -22.19M |
| Biodexa Pharmaceuticals Plc | -8.842M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -29.70M |
| Cash from Investing (Quarterly) | 21.39M |
| Cash from Financing (Quarterly) | 13.19M |
| Free Cash Flow Per Share (Quarterly) | -0.324 |
| Free Cash Flow to Equity (Quarterly) | -29.70M |
| Free Cash Flow to Firm (Quarterly) | -27.10M |
| Free Cash Flow Yield | -9.44% |